Mesothelioma Clinical Trials Search Tool
Find and explore mesothelioma clinical trials with our easy-to-use search tool and get connected with doctors conducting them. Search by location, trial phase, and specific disease presentation to discover cutting-edge treatment opportunities that may fit your diagnosis.
FILTER BY:
Details
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
Address: 3400 Civic Center Blvd West Pavilion, Philadelphia, PA 19104
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: No
- Peritoneal: Yes
- Pericardial: No
- Tunica Vaginalis: No
- Therapy Targeted: No
Type: Epitheliod, Sarcomatoid, Biphasic
Condition: Unresectable Pleural Mesothelioma
Description: This is a phase III, randomized, open-label, multicenter, global study to determine the efficacy and safety of Volrustomig (MEDI5752) + Carboplatin + Pemetrexed vs the investigator's choice of platinum + Pemetrexed or Nivolumab + Ipilimumab in participants with unresectable pleural mesothelioma.
Research Center: Abramson Cancer Center of the University of Pennsylvania
Treatment Interventions: DRUG: Volrustomig, DRUG: Pemetrexed, DRUG: Carboplatin, DRUG: Cisplatin, DRUG: Nivolumab, DRUG: Ipilimumab
Clinical Trial Number: NCT06097728
Phase: Phase 3
Status: Recruiting
